ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitive CRT in Patients With Unresectable Stage 3 EGFRm NSCLC"
By
ecancer
FEATURING
Suresh Ramalingam
By
ecancer
FEATURING
Suresh Ramalingam
Login to view comments.
Click here to Login
